For: | Echeverría N, Comas V, Aldunate F, Perbolianachis P, Moreno P, Cristina J. In the era of rapid mRNA-based vaccines: Why is there no effective hepatitis C virus vaccine yet? . World J Hepatol 2021; 13(10): 1234-1268 [PMID: 34786164 DOI: 10.4254/wjh.v13.i10.1234] |
---|---|
URL: | https://www.wjgnet.com/1948-5182/full/v13/i10/1234.htm |
Number | Citing Articles |
1 |
Ashraf Elbahrawy, Hassan Atalla, Mohamed Alboraie, Ahmed Alwassief, Ali Madian, Mohammed El Fayoumie, Ashraf A. Tabll, Hussein H. Aly. Recent Advances in Protective Vaccines against Hepatitis Viruses: A Narrative Review. Viruses 2023; 15(1): 214 doi: 10.3390/v15010214
|
2 |
Amirhosein Faghihkhorasani, Hanan Hassan Ahmed, Noor Muhammad Mashool, Mariem Alwan, Marjan Assefi, Aya Hussein Adab, Saman Yasamineh, Omid Gholizadeh, Moein Baghani. The potential use of bacteria and bacterial derivatives as drug delivery systems for viral infection. Virology Journal 2023; 20(1) doi: 10.1186/s12985-023-02183-z
|
3 |
Noura M. Alshiban, Munirah S. Aleyiydi, Majed S. Nassar, Nada K. Alhumaid, Thamer A. Almangour, Yahya M.K. Tawfik, Laila A. Damiati, Abdulaziz S. Almutairi, Essam A. Tawfik. Epidemiologic and clinical updates on viral infections in Saudi Arabia. Saudi Pharmaceutical Journal 2024; 32(7): 102126 doi: 10.1016/j.jsps.2024.102126
|
4 |
Kainat Ahmed, Sudhakar Jha. Oncoviruses: How do they hijack their host and current treatment regimes. Biochimica et Biophysica Acta (BBA) - Reviews on Cancer 2023; 1878(5): 188960 doi: 10.1016/j.bbcan.2023.188960
|
5 |
Alia Alassad, Mhd Jawad Al Rahwanji, Amal Yousfan, Sally Al Moualem, Arwa Farhat, Lama A. Youssef. Seroprevalence and trends of hepatitis B virus, hepatitis C virus and human immunodeficiency virus in Syrian blood donors at Damascus University Blood Center between 2004 and 2021. Frontiers in Public Health 2023; 11 doi: 10.3389/fpubh.2023.1174638
|
6 |
Ashraf A. Tabll, Sayed S. Sohrab, Ahmed A. Ali, Ana Petrovic, Sabina Steiner Srdarevic, Stjepan Siber, Marija Glasnovic, Robert Smolic, Martina Smolic. Future Prospects, Approaches, and the Government’s Role in the Development of a Hepatitis C Virus Vaccine. Pathogens 2023; 13(1): 38 doi: 10.3390/pathogens13010038
|
7 |
A. Kouakou Viviane, Sevede Daouda, Doumbia Moussa, E. Assohoun Stanislas, Dosso Mireille. Evaluation of viral hepatitis C screening at Institut Pasteur of Cte dIvoire from 2012 to 2022. African Journal of Biotechnology 2023; 22(11): 286 doi: 10.5897/AJB2023.17615
|